Skip to content
10-Q

Quarterly Report

ADAPTIN BIO, INC. APTN

0001213900-24-043492

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 5M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $380
Cash And Equivalents Q1 2024 · Dec 31, 2023 $380
Current Liabilities Q1 2024 · Mar 31, 2024 $170.45K
Current Liabilities Q1 2024 · Dec 31, 2023 $113.28K
Total Liabilities Q1 2024 · Mar 31, 2024 $170.45K
Total Liabilities Q1 2024 · Dec 31, 2023 $113.28K
Current Assets Q1 2024 · Mar 31, 2024 $380
Current Assets Q1 2024 · Dec 31, 2023 $380
Total Assets Q1 2024 · Mar 31, 2024 $380
Total Assets Q1 2024 · Dec 31, 2023 $380
Shares Diluted Q1 2024 · Mar 31, 2023 5M sh
Stockholders Equity Q1 2024 · Mar 31, 2023 −$31.55K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$27.3K
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.00
Eps Basic Q1 2024 · Mar 31, 2023 −$0.00
Sga Expense Q1 2024 · Mar 31, 2023 $4.25K
Net Income Q1 2024 · Mar 31, 2023 −$4.25K